A#1748 Fracture incidence in RA - RISE registry Incidence rate of MOF, hip Fx by disease activity 50% did not have CDAI available IR 12 per 1000py hip, 43 for MOF High activity worst, low/mod similar, remission is best Supports remission is better than LDA @RheumNow #ACR24 https://t.co/78FCLemfZD

• https://x.com/ericdeinmd/status/1858258817164685795/photo/1

Ab1676 discussed an intervention to change patient mindsets about side-effects of #methotrexate. Watch my video for @RheumNow on this abstract here: https://t.co/NxuxQ5wYda #ACR24

• Changing Mindsets about Methotrexate Side Effects

Can we do more to routinely assess fracture risk in RA? In RA pts ≥65, hip fracture & MOF are more common in pts with active disease, worse with higher disease activity ➡️Need better and more frequent bone health assessments in our RA pts Ab1748 #ACR24 @RheumNow https://t.co/whfnLnkpLd

• https://x.com/DrMiniDey/status/1858261331083730969/photo/1

A#1747 RA mortality by race/ethnicity Database study >200,000 pts had RA as contributing cause of death 5.1 ASMR in American Indian >>> all other groups No decr over time in grp, unlike other grps Odds of death 1.67 compared to white pop 10.8x higher in pts <44 #ACR24 @RheumNow https://t.co/nXLcQkQPu4

• https://x.com/ericdeinmd/status/1858254655928852760/photo/1
• https://x.com/ericdeinmd/status/1858254655928852760/photo/1

A#1746 companion for RA Like plenary for PsA, PBO response incr w time 1%/yr More trials in less affluent countries may be related to increasing PBO response in trials Possible reason: access to health care improves PBO in less affluent areas @RheumNow #ACR24 https://t.co/S3LffF8vPH

• https://twitter.com/ericdeinmd/status/1857803974922903912

RA patients on TOF with h/o ASCVD have 4x higher risk of MACE without statin (vs. TNFi). Prioritize statins for heart health in RA! #ACR24 @RheumNow ABST#1745 https://t.co/jRqXNU2T6d

• https://x.com/JihaRheum/status/1858252521044893744/photo/1
• https://x.com/JihaRheum/status/1858252521044893744/photo/1

A#1745 Post-hoc ORAL Surveillance - statin <1/4 on a statin, only 53% h/o ASCVD on statin Incr in LDL was less on Tofa pts on statin Among those on b/l statins, there is no incr risk compare to TNFi, esp pts h/o ASCVD If high risk on tofa, statin helps! @RheumNow #ACR24 #ACRBest https://t.co/7MGgUk7tfI

• https://x.com/ericdeinmd/status/1858249048085434638/photo/1
• https://x.com/ericdeinmd/status/1858249048085434638/photo/1
• https://x.com/ericdeinmd/status/1858249048085434638/photo/1

Wallace et al. Case control study. 648 cases 1241 controls. Cumulative glucocorticoid dose and risk MACE. Dose dependent increase in risk, OR 1.01 for 10% increase GC, 1.21 for 10-fold increase GC. @RheumNow #ACR24 Abstr#1719 https://t.co/wraiWOl1dv https://t.co/feht58RDNc

• Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a…
• https://x.com/RichardPAConway/status/1858248746078785887/photo/1

A#1744 AI for RA to improve scheduling in UK 39% pts meet quality metric for early intervention Input: RF, CRP, CCP, gender, age -> 51% accuracy (compare to first appt clinical accur 46%) Focusing on highest risk -> 88% accuracy -> 50% wait time for high-risk pts #ACR24 @RheumNow